Učitavanje...
Immune checkpoint inhibitors: recent progress and potential biomarkers
Cancer growth and progression are associated with immune suppression. Cancer cells have the ability to activate different immune checkpoint pathways that harbor immunosuppressive functions. Monoclonal antibodies that target immune checkpoints provided an immense breakthrough in cancer therapeutics....
Spremljeno u:
| Izdano u: | Exp Mol Med |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group UK
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6292890/ https://ncbi.nlm.nih.gov/pubmed/30546008 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s12276-018-0191-1 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|